Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera’s Board of Directors Reaffirms Support of Merger with Pfizer
Revised transaction values Metsera at up to $86.25 per share Metsera’s Board of Directors unanimously recommends that Metsera stockholders approve the adoption... Read more.
The Future of Longevity and Wellness Investment to Be Highlighted at This Year’s Global Wellness Summit in Dubai
Forward-looking sessions will explore where the smart money is now flowing in wellness, the business models and markets most capturing investors’ attention,... Read more.
MEDIA ADVISORY – Secretary of State McLean to highlight federal budget investments in Victoria
GATINEAU, QC, Nov. 7, 2025 /CNW/ – The Honourable Stephanie McLean, Secretary of State (Seniors), will host an event at Royal Athletic Park to highlight federal... Read more.
HTCO Announces Initial Closing of $3 Million Strategic Financing to Accelerate Digital Transformation
NEW YORK, Nov. 7, 2025 /PRNewswire/ — HTCO (NASDAQ: HTCO) today announced that it has entered into a financing agreement for an investment of up to US $20... Read more.
Boehringer awarded FDA Commissioner’s National Priority Voucher for HERNEXEOS® in HER2 lung cancer
RIDGEFIELD, Conn., Nov. 7, 2025 /PRNewswire/ — The U.S. Food & Drug Administration (FDA) has awarded a Commissioner’s National Priority Voucher (CNPV)... Read more.
Healthcare Therapy Services, Inc. Notifies Patients of Data Security Incident
GREENWOOD, Ind., Nov. 7, 2025 /PRNewswire/ — Healthcare Therapy Services, Inc. (“HTS”) has become aware of a data security incident that may have... Read more.
GenerativeX Introduces “ExcelenceAI” – The AI Agent for Deal-Ready Financial Modeling in Excel
In the news release, GenerativeX Introduces “ExcelenceAI” – The AI Agent for Deal-Ready Financial Modeling in Excel, issued on November 4, 2025... Read more.
Evommune Announces Closing of its Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
PALO ALTO, Calif., Nov. 7, 2025 /PRNewswire/ — Evommune, Inc. (“Evommune”), a clinical-stage biotechnology company developing innovative therapies... Read more.
Lazydays Announces Plan to Delist from Nasdaq
TAMPA, Fla., Nov. 7, 2025 /PRNewswire/ — Lazydays Holdings, Inc. (“Lazydays,” the “Company,” “we” or “our”)... Read more.
Bit Digital, Inc. Announces Date for Third Quarter 2025 Financial Results and Conference Call
NEW YORK, Nov. 7, 2025 /PRNewswire/ — Bit Digital, Inc. (Nasdaq: BTBT) (“Bit Digital” or the “Company”) today announced that it will... Read more.